GUMDROP : UMD - Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer. A Phase III Randomized Trial

Created by Nancy Dawson, last modified on Jun 25, 2013
Description:

RATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens. Radiation therapy uses high-energy x-rays to kill tumor cells.

PURPOSE: This randomized phase III trial studies androgen-deprivation therapy and radiation therapy in treating patients with prostate cancer.

Link:http://clinicaltrials.gov/ct2/show/NCT01368588
Site:University of Maryland
Principal Investigator:Young Kwok, MD